The Max Planck Institute of Molecular Physiology (German: Max-Planck-Institut für molekulare Physiologie) is located in Dortmund, Germany next to the Dortmund University of Technology
The Latest Bing News on:
Max Planck Institute for Molecular Physiology Research
- Understanding how microbiota thrive in their human hosts
A research team lead by scientists from the Max Planck Institute for Biology, Tübingen, has now made substantial progress in understanding how gut bacteria succeed in their human hosts on a molecular ...
- Technical Assistant (f/m/d) with experience in molecular biology
The Dierickx lab at the Max Planck Institute for Heart and Lung Research, W. G. Kerckhoff Institute in Bad Nauheim is looking for a Technical Assistant (f/m/d) with experience in molecular biology, ...
- Tobias Kind, Leader in Computational Metabolomics, Joins Enveda Biosciences
Enveda Biosciences, a pioneer in small molecule drug discovery using machine learning and metabolomics to harness the potential of natural products, today announced that Tobias Kind, Ph.D., will join ...
- How Gut Bacteria Thrive in Their Human Hosts
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on ...
- Biology Letters
In their paper published in the journal Biology Letters, ... A team of researchers from Trier University and the Max Planck Institute for Evolutionary Biology reports that there are large amounts ...
The Latest Google Headlines on:
Max Planck Institute for Molecular Physiology Research
The Latest Bing News on:
Max Planck Institute for Molecular Physiology Discovery
- Taking your time makes a difference – Brain development differs between Neanderthals and modern humans
Felipe Mora-Bermúdez, the lead author of the study, describes the discovery: “We found that three modern human amino acids in two of the proteins cause a longer metaphase, a phase where ...
- Tobias Kind, Leader in Computational Metabolomics, Joins Enveda Biosciences
Enveda Biosciences, a pioneer in small molecule drug discovery using machine ... Dr Kind was a postdoctoral fellow at Max-Planck-Institute of Molecular Plant Physiology, Golm, Germany, one of ...
- Tobias Kind, Leader in Computational Metabolomics, Joins Enveda Biosciences
July 20, 2022--(BUSINESS WIRE)--Enveda Biosciences, a pioneer in small molecule drug discovery using machine learning ... Dr Kind was a postdoctoral fellow at Max-Planck-Institute of Molecular Plant ...
- Tobias Kind, Leader in Computational Metabolomics, Joins Enveda Biosciences
July 20, 2022--(BUSINESS WIRE)--Enveda Biosciences, a pioneer in small molecule drug discovery using ... postdoctoral fellow at Max-Planck-Institute of Molecular Plant Physiology, Golm, Germany ...
- Tobias Kind, Leader in Computational Metabolomics, Joins Enveda Biosciences
Enveda Biosciences, a pioneer in small molecule drug discovery using machine learning and metabolomics to harness the potential of natural products, today announced that Tobias Kind, Ph.D., will join ...
